Navigation Links
Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid

Quincy, MA (PRWEB) September 02, 2014

Myriant Corporation, a global renewable chemicals company, announced today the signage of a distribution agreement with Azelis Group, a specialty chemicals distribution leader. Azelis is now distributing Myriant’s bio-succinic acid in the Nordics, Benelux, France, Iberia, Italy, the United Kingdom and Ireland, targeting customers in the industrial and base chemicals markets.

“As a global chemical distribution powerhouse, Azelis offers a far-reaching chemical portfolio with extensive distribution networks providing Myriant the necessary support and connections with chemical companies seeking to integrate “green” chemicals into a wide range of applications,” said David LeBlanc, Head of Global Sales and Marketing for Myriant.

Myriant currently supplies bio-succinic acid from its flagship facility located in Lake Providence, Louisiana, with nameplate capacity of 30 million pounds per year. Globally, the annual worldwide market for succinic acid is estimated at approximately $7.5 billion in existing and new applications, in the field of polymers, urethanes, plasticizers and coatings. Myriant's high purity bio-succinic acid is made from renewable feedstocks and is chemically equivalent to petroleum-based succinic acid while providing a lower environmental footprint. Myriant’s bio-succinic acid reduces harmful green house gas emissions by 94% compared to petroleum-derived succinic acid and by 96% compared to petroleum-derived adipic acid, a chemical that succinic acid can replace.

Azelis, a global leader in the sales, marketing and distribution of specialty chemicals, has a strong commitment to sustainability and achieving reduction of green house gases is one of its top corporate priorities. “We are delighted to partner with Myriant for this leading and exciting new generation product,” said Laurent Nataf, COO Azelis. “Myriant further strengthens Azelis’ offering in the renewable resources based chemistry for production of more sustainable polymers. We are currently experiencing a growing demand for sustainable products and we believe Myriant will be a part of sourcing these new renewable chemicals.”

About Myriant Corporation
Myriant is a global leader innovating and commercializing bio-based chemical intermediates with a focus on bio-succinic acid, bio-butanediol and bio-acrylic acid. Myriant is currently commercializing bio-succinic acid from its flagship plant in Lake Providence, LA.

About Azelis
Azelis is the leading global specialty chemicals distributor providing a diverse range of innovative products and services. We serve 20,000 customers in the coatings, chemicals, rubber & plastic additives, food & health, animal nutrition, pharma and personal care industries.

Through sourcing and distribution channels in every major market around the world, Azelis with its corporate service centre in Antwerp, Belgium, offers chemical producers market penetration, in-depth local knowledge, value-added services and tailored multi-territory solutions. Azelis, backed by private equity investor 3i Investments PLC, has a turnover of €1 billion and employs around 1,100 knowledgeable people located in more than 37 facilities in 34 countries across Europe, China, Australia, Canada, India, Japan, Malaysia and Singapore.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
2. Myriant to Participate in U.S. DOE Biomass 2013 Conference
3. Myriant Selected as a 2013 Red Herring Top 100 Global Company
4. Myriant to Participate in BIO Pacific Rim Summit
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
8. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
9. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
10. Tackling the European market of nanoimprint lithography
11. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
Post Your Comments:
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):